Details for 2019745306

Up to date per 04.04.2026

Actions

Title / Product Name

KREBS BEHANDLUNGSVERFAHREN BASIEREND AUF TP53 MUTATION STATUS UND HYPERMUTATION STATUS

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2019745306

EP Publication Number

3810810

E-Number

1663550

Language

PCT Number

JP19025995

Publication Date

28.04.2021 A

06.03.2024 B1

Registration Date

06.03.2024

AT Publication Date

15.03.2024

Application Date

18.06.2019

Registration Number

Priorities

19.06.2018

201862686960 P

IPC

C12Q 1/6886 20180101AFI20230807BHEP

Maximum Duration of Protection

18.06.2039

Owner

Takeda Pharmaceutical Company Limited1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka 541-0045JP

Representative

No representatives present

Inventor

OHASHI, Akihiroc/o TAKEDA PHARMACEUTICAL COMPANY LIMITED 26-1, Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa 251-0012JP

IWAI, Kenichic/o TAKEDA PHARMACEUTICAL COMPANY LIMITED 26-1, Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa 251-0012JP

NAMBU, Tadahiroc/o TAKEDA PHARMACEUTICAL COMPANY LIMITED 26-1, Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa 251-0012JP

YAMANAKA, Kazunoric/o TAKEDA PHARMACEUTICAL COMPANY LIMITED 26-1, Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa 2510012JP

OTAKE, Kentaroc/o TAKEDA PHARMACEUTICAL COMPANY LIMITED 26-1, Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa 2510012JP

NIU, Huifengc/o Millennium Pharmaceuticals, Inc. 40 Landsdowne Street Cambridge, Massachusetts 02139US

SHIN, Hyunjinc/o Millennium Pharmaceuticals, Inc. 40 Landsdowne Street Cambridge, Massachusetts 02139US

KOENIG, Erik Michaelc/o Millennium Pharmaceuticals, Inc. 40 Landsdowne Street Cambridge, Massachusetts 02139US